{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T15:58:17Z","timestamp":1791475097821,"version":"4.3.4"},"reference-count":12,"publisher":"BMJ","issue":"1","license":[{"start":{"date-parts":[[2021,8,26]],"date-time":"2021-08-26T00:00:00Z","timestamp":1629936000000},"content-version":"unspecified","delay-in-days":25,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["Lupus Sci Med"],"accepted":{"date-parts":[[2021,8,3]]},"published-print":{"date-parts":[[2021,8]]},"abstract":"<jats:sec>\n                  <jats:title>Background<\/jats:title>\n                  <jats:p>The very long-term consequences of absence of remission in lupus nephritis (LN) remain understudied.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>In this retrospective analysis, we studied a selected cohort of 128 patients with biopsy-proven class III, IV or V incident LN followed for a median period of 134 months (minimum 25). Remission was defined as a urine protein to creatinine (uP:C) ratio &lt;0.5\u2009g\/g and a serum creatinine value &lt;120% of baseline. Renal relapse was defined as the reappearance of a uP:C &gt;1\u2009g\/g, leading to a repeat kidney biopsy and treatment change. Poor long-term renal outcome was defined as the presence of chronic kidney disease (CKD).<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>Twenty per cent of patients never achieved renal remission. Their baseline characteristics did not differ from those who did. Absence of renal remission was associated with a threefold higher risk of CKD (48% vs 16%) and a 10-fold higher risk of end-stage renal disease (20% vs 2%). Patients achieving early remission had significantly higher estimated glomerular filtration rate (eGFR) at last follow-up compared with late remitters. Accordingly, patients with CKD at last follow-up had statistically longer time to remission. Among patients who achieved remission, 32% relapsed, with a negative impact on renal outcome, that is, lower eGFR values and higher proportion of CKD (33% vs 8%).<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusion<\/jats:title>\n                  <jats:p>Early remission should be achieved to better preserve long-term renal function.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1136\/lupus-2021-000533","type":"journal-article","created":{"date-parts":[[2021,8,26]],"date-time":"2021-08-26T12:41:06Z","timestamp":1629981666000},"page":"e000533","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":23,"title":["Absence of renal remission portends poor long-term kidney outcome in lupus nephritis"],"prefix":"10.1136","volume":"8","author":[{"given":"Val\u00e9rie","family":"Pirson","sequence":"first","affiliation":[{"name":"P\u00f4le de Pathologies Rhumatismales Inflammatoires et Syst\u00e9miques, Institut de Recherche Exp\u00e9rimentale et Clinique, Universit\u00e9 catholique de Louvain, Brussels, Belgium"},{"name":"Rheumatology Department, Cliniques universitaires Saint-Luc, Brussels, Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8844-9715","authenticated-orcid":false,"given":"Antoine","family":"Enfrein","sequence":"additional","affiliation":[{"name":"Internal Medicine Department, Centre Hospitalier Universitaire de Nantes, Nantes, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fr\u00e9d\u00e9ric A","family":"Houssiau","sequence":"additional","affiliation":[{"name":"P\u00f4le de Pathologies Rhumatismales Inflammatoires et Syst\u00e9miques, Institut de Recherche Exp\u00e9rimentale et Clinique, Universit\u00e9 catholique de Louvain, Brussels, Belgium"},{"name":"Rheumatology Department, Cliniques universitaires Saint-Luc, Brussels, Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Farah","family":"Tamirou","sequence":"additional","affiliation":[{"name":"P\u00f4le de Pathologies Rhumatismales Inflammatoires et Syst\u00e9miques, Institut de Recherche Exp\u00e9rimentale et Clinique, Universit\u00e9 catholique de Louvain, Brussels, Belgium"},{"name":"Rheumatology Department, Cliniques universitaires Saint-Luc, Brussels, Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2021,8,26]]},"reference":[{"key":"2025091513524849000_8.1.e000533.1","doi-asserted-by":"crossref","first-page":"825","DOI":"10.2215\/CJN.05780616","article-title":"Update on lupus nephritis","volume":"12","author":"Almaani","year":"2017","journal-title":"CJASN"},{"key":"2025091513524849000_8.1.e000533.2","doi-asserted-by":"publisher","DOI":"10.1097\/01.md.0000091181.93122.55"},{"key":"2025091513524849000_8.1.e000533.3","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2001180"},{"key":"2025091513524849000_8.1.e000533.4","doi-asserted-by":"crossref","first-page":"2070","DOI":"10.1016\/S0140-6736(21)00578-X","article-title":"Efficacy and safety of voclosporin versus placebo for lupus nephritis (Aurora 1): a double-blind, randomised, multicentre, placebo-controlled, phase 3 trial","volume":"397","author":"Rovin","year":"2021","journal-title":"The Lancet"},{"key":"2025091513524849000_8.1.e000533.5","unstructured":"Furie R , Aroca G , Alvarez A . Two-Year results from a randomized, controlled study of Obinutuzumab for proliferative lupus nephritis. ACR meeting Abstracts, 2020. Available: https:\/\/acrabstracts.org\/abstract\/two-year-results-from-a-randomized-controlled-study-of-obinutuzumab-for-proliferative-lupus-nephritis\/ [Accessed 05 Jul 2021]."},{"key":"2025091513524849000_8.1.e000533.6","doi-asserted-by":"publisher","DOI":"10.1097\/01.ASN.0000108969.21691.5D"},{"key":"2025091513524849000_8.1.e000533.7","first-page":"79","article-title":"The course of lupus nephritis: contribution of serial renal biopsies","volume":"6","author":"Morel-Maroger","year":"1976","journal-title":"Adv Nephrol Necker Hosp"},{"key":"2025091513524849000_8.1.e000533.8","doi-asserted-by":"publisher","DOI":"10.1136\/lupus-2015-000123"},{"key":"2025091513524849000_8.1.e000533.9","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1002\/art.39026","article-title":"Predictors of long-term renal outcome in lupus nephritis trials: lessons learned from the Euro-Lupus nephritis cohort","volume":"67","author":"Dall'Era","year":"2015","journal-title":"Arthritis Rheumatol"},{"key":"2025091513524849000_8.1.e000533.10","doi-asserted-by":"publisher","DOI":"10.1136\/lupus-2017-000213"},{"key":"2025091513524849000_8.1.e000533.11","article-title":"Medium versus high initial prednisone dose for remission induction in lupus nephritis: a propensity score matched analysis","author":"Tselios","year":"2021","journal-title":"Arthritis Care Res"},{"key":"2025091513524849000_8.1.e000533.12","doi-asserted-by":"publisher","DOI":"10.1681\/ASN.2008101028"}],"container-title":["Lupus Science &amp; Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/lupus-2021-000533","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,15]],"date-time":"2025-09-15T20:52:55Z","timestamp":1757969575000},"score":1,"resource":{"primary":{"URL":"https:\/\/lupus.bmj.com\/lookup\/doi\/10.1136\/lupus-2021-000533"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,8]]},"references-count":12,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2021,8,26]]},"published-print":{"date-parts":[[2021,8]]}},"alternative-id":["10.1136\/lupus-2021-000533"],"URL":"https:\/\/doi.org\/10.1136\/lupus-2021-000533","relation":{},"ISSN":["2053-8790"],"issn-type":[{"value":"2053-8790","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,8]]}}}